Factors associated with mortality in bacteremic patients with hematologic malignancies.
about
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactamsNew Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesAcute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signalingAntimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality.Nosocomial infection in adult admissions with hematological malignancies originating from different lineages: a prospective observational study.Prior colonization is associated with increased risk of antibiotic-resistant Gram-negative bacteremia in cancer patientsBloodstream infections and mortality-related factors in febrile neutropenic cancer patients.Reversal of Acute Kidney Injury-Induced Neutrophil Dysfunction: A Critical Role for Resistin.Management of gram-positive bacterial infections in patients with cancer.Differential effects of kidney-lung cross-talk during acute kidney injury and bacterial pneumonia.Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia.Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms.Bloodstream infections in patients with solid tumors.Multidrug-resistant bacteria in hematology patients: emerging threats.A review of the role of immune cells in acute kidney injury.Prior infections are associated with increased mortality from subsequent blood-stream infections among patients with hematological malignancies.A prospective survey of febrile events in hematological malignancies.Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital.Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients.Klebsiella pneumoniae pharyngitis mimicking malignancy: a diagnostic dilemma.Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies.Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies.Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients.Relapsing bloodstream infections during treatment of acute leukemia.Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.Nosocomial Klebsiella pneumoniae bacteraemia in adult cancer patients--characteristics of neutropenic and non-neutropenic patients.Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance.
P2860
Q24236653-0461F8D5-F216-4D2E-9D3F-E6EACE3AC315Q26799580-00559CF6-5301-46FF-852B-70E430C38B5CQ30503500-5DEBE608-79AA-4377-9565-2D5AA02F9F7CQ33760545-91E4F404-8F66-4BF0-80CB-AB49DCBC182DQ34525373-D82B48B6-CD00-4EF7-94AE-8007CE845656Q34557550-A2C9FF77-108F-42D3-B303-F75E26892374Q35634071-FC4A674B-5CCC-4637-A3E6-948ED3B3C073Q36516581-E35EA3DE-78B2-4B97-8696-110EAEE1D08AQ36978604-4BB401F2-2F15-4DCA-A33B-636470ECBC7EQ37899198-8D3E0233-A86C-4839-94FD-342258596AFCQ38280048-FD251C75-9712-46FE-B99D-F3EB48658B31Q38467189-A6BC020B-4092-481B-950E-E3395C4D20F2Q38538705-DCEEDBAD-0957-4B05-8ECD-05274D4725DAQ38703440-9EBA9345-29B7-4106-9D88-0C281A2000D5Q38838498-CFF1E3B7-1D29-4AEA-B7E7-3F8C3D53AE46Q40096454-05F4FAE0-A81D-4FD1-9F5D-EF8AFB934F2BQ40188573-860751E4-FAEB-4835-A965-4B290349E259Q40304457-3A68703A-58EB-4E92-AFD1-04E67912BE05Q40500618-BFE2A5C7-CD31-4EF3-AC94-9333E80BCA94Q41153995-3AAD47A8-78AB-43CB-8638-12BE4EFB04F6Q41195981-A2A28971-B4C7-47A3-8ACA-3B5054B1F48EQ42199910-C8C6E872-F7A7-4A82-B8B8-FAD855F177BBQ42210701-4BE66A99-7FC1-480B-B83A-5BE0807F6785Q42558452-837707CA-4760-4A8D-B3FA-A7103450C04EQ42712877-348D6610-F10C-44A9-A3B6-00E5CCCD7C1CQ43786316-A51CBCDA-F551-4CF9-A8BE-7819AE599DDBQ45355151-56C39DB3-193F-4A48-A890-A76DBDC4C8F5Q45365673-438F4256-D018-4568-8A74-DB3037070490Q48876913-CA2A8763-71C0-4707-8BFA-B559EB908109Q55496879-56CEAC46-F1F6-458B-92A2-87256DC130C4
P2860
Factors associated with mortality in bacteremic patients with hematologic malignancies.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Factors associated with mortality in bacteremic patients with hematologic malignancies.
@en
Factors associated with mortality in bacteremic patients with hematologic malignancies.
@nl
type
label
Factors associated with mortality in bacteremic patients with hematologic malignancies.
@en
Factors associated with mortality in bacteremic patients with hematologic malignancies.
@nl
prefLabel
Factors associated with mortality in bacteremic patients with hematologic malignancies.
@en
Factors associated with mortality in bacteremic patients with hematologic malignancies.
@nl
P2093
P50
P1476
Factors associated with mortality in bacteremic patients with hematologic malignancies.
@en
P2093
Eva Montuori
Fiammetta Leone
Giovanni Fadda
Livio Pagano
Luca Laurenti
Mario Tumbarello
Morena Caira
Teresa Spanu
P304
P356
10.1016/J.DIAGMICROBIO.2009.02.008
P577
2009-04-02T00:00:00Z